The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 23.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 25.00
High: 25.00
Low: 25.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Brodie and Stone

27 Sep 2021 07:00

RNS Number : 9799M
Creightons PLC
27 September 2021
 

27 September 2021

 

CREIGHTONS plc ("Creightons" or the "Company")

Acquisition of Brodie and Stone Holdings Limited and its subsidiary, Brodie and Stone International Limited

and

Total Voting Rights

· Total consideration of £4.8 million (£3.7 million in cash and 1,000,000 ordinary shares in Creightons plc)

 

· Brands being acquired include T Zone, Natural World and Janina

 

Creightons plc (LSE: CRL), manufacturers of personal care, beauty, and fragrance products, announces that it has acquired the entire share capital of Brodie and Stone Holdings Limited ("BSH") and its subsidiary, Brodie and Stone International Limited ("BSI") (together the "Transaction").

Brodie and Stone sells products under the T Zone, Natural World and Janina brands, primarily to retailers in the UK market.

The consideration for the transaction is approximately £4.8 million comprising £3.7 million in cash and the issue of 1,000,000 ordinary shares of 1p each in the Company ("New Ordinary Shares") at the volume weighted average middle market CRL quoted price for preceding 5 Business Days of £1.146 per share ("Consideration Shares").

The Consideration Shares will be subject to a lock-in mechanism for twelve months.

Application will be made by the Company to the Financial Conduct Authority and to the London Stock Exchange for the New Ordinary Shares, which will rank pari passu with all existing ordinary shares, to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). It is expected that Admission will become effective and dealings will commence on or around 1 October 2021.

The gross assets applicable to the Transaction as derived from the most recently available accounts of BSH and BSI to 31 December 2020 were £2.2 million and the turnover was £5.8million, with profits before tax of £0.5million, as adjusted to remove the benefit of an historic intercompany loan write-off.

The Transaction represents a further important development for Creightons plc following the acquisition of Balance Active Formula from Brodie and Stone in June 2019 and the recent acquisition of Emma Hardie Limited. The Balance Active Formula brand has been very successful in driving significant growth and improved margins in the branded division with existing and new customers both in the UK and in international markets. The intention is to repeat the success of that acquisition with T Zone, Natural World and Janina. These brands are placed well in the Company's core market position and therefore, enhance the current brand portfolio by strengthening the coverage and category presence with key mainstream retailers in the UK market, in the core performing categories of both skincare and haircare. There are also significant opportunities for extending distribution, particularly in international markets. The brands provide good vehicles through which product innovation can be harnessed and delivered quickly to the consumer. Both manufacturing and management synergies will drive a higher return in the brands.

Mr Bernard Johnson Managing Director of the Company commented: 'We are pleased to announce the acquisition of Brodie and Stone which will further strengthen our position in the UK grocery market. It is further evidence of our ambition and commitment to expand our branded business as announced during our recent investor presentation.'

Total Voting Rights

On Admission, the number of shares in issue will be 67,452,243 ordinary shares of 1p each and therefore, the total number of voting rights in the Company will be 67,452,243.

The above statement of voting capital may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

 

Enquiries - Analysts and Investors:

Nicholas O'Shea, Director, Creightons Plc 01733 281000

Roland Cornish / Felicity Geidt, Beaumont Cornish Limited 0207 628 3396

Press Nigel Szembel, Anagallis Communications Limited 07802 362088

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFQLFLFKLFBBX
Date   Source Headline
15th Mar 202410:52 amRNSBlock listing Interim Review
7th Mar 20247:00 amRNSDirectorate Change
4th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSDirectorate Change
25th Sep 202311:50 amRNSDirector/PDMR Shareholding
15th Sep 20235:24 pmRNSBlock listing Interim Review
14th Sep 20239:52 amRNSResult of AGM
1st Sep 20235:17 pmRNSDirector/PDMR Shareholding
1st Sep 20235:05 pmRNSDirector/PDMR Shareholding
25th Aug 20233:32 pmRNSDirector/PDMR Shareholding
31st Jul 20232:53 pmRNSReplacement: Director/PDMR Shareholding
24th Jul 202311:54 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSAudited preliminary results
31st Mar 202310:49 amRNSTotal Voting Rights
17th Mar 20237:00 amRNSBlock listing Interim Review
16th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20232:05 pmRNSSecond Price Monitoring Extn
27th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSHalf-year Report
29th Nov 20224:41 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20227:00 amRNSInterim Results 2022 - announcement, presentations
27th Sep 20227:00 amRNSUpdate on Emma Hardie, Trading in own shares & TVR
20th Sep 20229:22 amRNSBlock Listing Update
24th Aug 20221:01 pmRNSResult of AGM
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSResults for year to end 31 March 2022
11th Jul 20227:00 amRNSPreliminary Results, investor/analyst presentation
4th Jul 20224:42 pmRNSTotal Voting Rights
7th Jun 20223:28 pmRNSTotal Voting Rights
3rd May 20226:09 pmRNSTotal Voting Rights
12th Apr 20224:33 pmRNSDirector/PDMR Dealing, Total Voting Rights
21st Mar 202211:37 amRNSBlock listing Interim Review
7th Mar 20229:59 amRNSTotal Voting Rights
14th Jan 20222:58 pmRNSTotal Voting Rights
30th Dec 20217:00 amRNSHalf-year Report
15th Dec 20212:52 pmRNSNotice of Interim Results & Investors Presentation
6th Dec 20215:38 pmRNSTotal Voting Rights
25th Nov 20216:18 pmRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Nov 20214:49 pmRNSDirector/PDMR Shareholding
18th Nov 202111:55 amRNSDirector/PDMR Shareholding
17th Nov 20211:58 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.